Stay updated with breaking news from Olivia Cavlan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 14th Annual...
Press release content from Business Wire. The AP news staff was not involved in its creation.
Proof-of-concept immuno-oncology collaboration with AstraZeneca to build understanding of prostate cancer Alchemab's advanced analytics to be used to analyse patient immune responses, identify
Posted on 802 Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, today announces the completion of a £60 million ($82 million) Series A financing round. The international investment syndicate is led by RA Capital Management, with participation from Lightstone Ventures, Data Collective VC (DCVC), DHVC, SV Health Investors and the Dementia Discovery Fund. The company was created by SV Health Investors who led the Seed...
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington's disease Alchemab using unique approach to explore adaptive immunity identifying naturally protective antibodies in 'resilient patients' to specific diseases Innovate UK Grant to support the finding of a disease-modifying therapy for Huntington's disease (HD), a degenerative disease with no cure and no therapies to prevent progression Alchemab is working in collaboration with Medicines Discovery Catapult, a not-for-profit, government-funded organisation supporting UK life science innovators H...